Moreover, the activity of GSK3β was augmented in other CKDs, such as focal segmental glomerular sclerosis (FSGS) (Chen et al., 2021), folic acid (FA) nephropathy (Chen et al., 2021), and chromic allograft nephropathy (Gong et al., 2008; Yan et al., 2012). This evidence concerns the gene GSK3B and focal segmental glomerulosclerosis.